Bing-Mae Chen
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 11
- Nanoparticle-Based Drug Delivery 11
-
- Glycosylation and Glycoproteins Research 3
- Advanced biosensing and bioanalysis techniques 3
- Co-authors
- Steve R. Roffler (20 shared papers)Tian‐Lu Cheng (14 shared papers)Yu-Cheng Su (11 shared papers)Kai‐Hsiang Chuang (9 shared papers)Pierre‐Alain Burnouf (4 shared papers)Chia-Jung Chang (2 shared papers)Kuo‐Hsiang Chuang (2 shared papers)Yuan-Tsong Chen (2 shared papers)
- Journals
- Bioconjugate Chemistry (5 papers)ACS Nano (3 papers)Nature Communications (2 papers)Cancer Gene Therapy (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- TaiwanUnited StatesIsrael
In The Last Decade
Bing-Mae Chen
20 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Biomaterials 435
- Pharmaceutical Science 88
- Radiology, Nuclear Medicine and Imaging 227
- Immunology 216
- Surfaces, Coatings and Films 56
Countries citing papers authored by Bing-Mae Chen
This map shows the geographic impact of Bing-Mae Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing-Mae Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing-Mae Chen more than expected).
Fields of papers citing papers by Bing-Mae Chen
This network shows the impact of papers produced by Bing-Mae Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing-Mae Chen. The network helps show where Bing-Mae Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing-Mae Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 193 | |
| 2 | 2012 | 104 | |
| 3 | 2020 | 100 | |
| 4 | 2018 | 96 | |
| 5 | 2010 | 82 | |
| 6 | 2005 | 77 | |
| 7 | 2007 | 75 | |
| 8 | 2017 | 69 | |
| 9 | 2017 | 56 | |
| 10 | 2014 | 51 | |
| 11 | 2016 | 39 | |
| 12 | 2010 | 32 | |
| 13 | 2015 | 32 | |
| 14 | 2017 | 25 | |
| 15 | 2003 | 21 | |
| 16 | 2004 | 16 | |
| 17 | 2013 | 15 | |
| 18 | 2018 | 15 | |
| 19 | 2006 | 13 | |
| 20 | 2024 | 13 |
About Bing-Mae Chen
Bing-Mae Chen is a scholar working on Biomaterials, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology and Biomedical Engineering, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer Research and Treatments (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). The work is most often cited by research in Biomaterials (435 citations), Pharmaceutical Science (88 citations), Radiology, Nuclear Medicine and Imaging (227 citations), Immunology (216 citations) and Surfaces, Coatings and Films (56 citations). Bing-Mae Chen has collaborated with scholars based in Taiwan, United States and Israel. Frequent co-authors include Steve R. Roffler, Tian‐Lu Cheng, Yu-Cheng Su, Kai‐Hsiang Chuang, Pierre‐Alain Burnouf, Chia-Jung Chang, Kuo‐Hsiang Chuang, Yuan-Tsong Chen, Chien‐Hsiun Chen and Jer-Yuarn Wu. Their work appears in journals such as Bioconjugate Chemistry, ACS Nano, Nature Communications, Cancer Gene Therapy and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.